医疗特长：从事医教研工作30多年，具有丰富的临床经验，致力肝脏疾病的诊治，尤其擅长脂肪性肝病、病毒性肝病、自身免疫性肝病、药物性肝病等。荣获首届岭南名医、羊城好医生称号。负责成立中山一院脂肪肝诊治中心，组建脂肪肝多学科诊疗团队，率先开展国际前沿的诊疗方法。参与多个中国临床指南的制定，包括：2022年肝硬化合并糖尿病患者血糖管理专家共识、2019年脂肪性肝病诊疗规范化的专家建议、2018年非酒精性脂肪性肝病防治指南、2018年酒精性肝病防治指南等。研究方向：1、脂肪性肝病2、病毒性肝病（乙肝、丙肝等）3、自身免疫性肝病4、药物性肝病主要教育和工作经历：1984年医学本科毕业后相继获硕士及博士学位，曾在著名学府美国斯坦福大学 (Stanford University）医学院消化内科完成博士后研究。社会兼职：1、中华医学会肝病学分会脂肪肝和酒精肝学组委员2、中华医学会消化病学分会肝胆组委员3、中华医学会老年医学分会消化病学组委员4、广东省医学会肝脏病学分会副主任委员兼脂肪肝学组组长5、广东省肝病学会脂肪肝专业委员会主任委员6、广东省临床医学学会脂肪肝专委会主任委员7、广东省健康管理学会脂肪肝多学科诊治专业委员会主任委员8、广东省医学会感染病学分会常委9、广东省医师协会感染病学分会常委10、广东省预防医学会感染病学专业委员会常委论著：发表研究论文多篇，2022年和2009年在著名杂志Metabolism (IF: 13.9) 和Hepatology (IF: 17.3 ) 发表论著。近5年代表作如下：Feng X, Lin Y, Zhuo S, Zhi D, Shao C, Ye J, Zhong B（通讯作者）. Treatment of Obesity and Metabolic-Associated Fatty Liver Disease with a Diet or Orlistat: A Randomized Controlled Trial. Am J Clin Nutr 2023; S0002-9165(23)04154-0. (IF: 8.472)Shao C, Xu L, Lei P, Wang W, Feng S, Ye J, Zhong B（通讯作者）. Metabolomics to identify fingerprints of carotid atherosclerosis in nonobese metabolic dysfunction-associated fatty liver disease. J Transl Med 2023; 21: 12. (IF: 8.440)Shao C, Ye J, Li X, Lin Y, Feng S, Liao B, Wang W, Gong X, Zhong B（通讯作者）. Discrepancies between Nonalcoholic and Metabolic-associated Fatty Liver Disease by Multiple Steatosis Assessment. J Clin Transl Hepatol 2022; 10: 1013-1026. (IF: 5.065)Lin Y, Feng X, Cao X, Miao R, Sun Y, Li R, Ye J, Zhong B（通讯作者）. Age patterns of nonalcoholic fatty liver disease incidence: heterogeneous associations with metabolic changes. Diabetol Metab Syndr 2022; 14: 181. (IF: 5.395)Ye J, Zhuang X, Li X, Gong X, Sun Y, Wang W, Feng S, Wu T, Zhong B（通讯作者）. Novel metabolic classification for extrahepatic complication of metabolic associated fatty liver disease: A data-driven cluster analysis with international validation. Metabolism 2022; 136: 155294. (IF: 13.934)He J, Ye J, Sun Y, Feng S, Chen Y, Zhong B（通讯作者）. The Additive Values of the Classification of Higher Serum Uric Acid Levels as a Diagnostic Criteria for Metabolic-Associated Fatty Liver Disease. Nutrients 2022;14: 3587. (IF: 6.706)Luo L, Ye J, Shao C, Lin Y, Sun Y, Feng S, Wang W, Zhong B（通讯作者）. Vitamin D Status Presents Different Relationships with Severity in Metabolic-Associated Fatty Liver Disease Patients with or without Hepatitis B Infection. Nutrients name="_Hlk112710172"> 2022;14:2114. (IF: 6.706)Wu T, Ye J, Gong X, Li X, Shao C, Li F, Lin Y, Ma Q, Mai W, Wang W, Feng ST, Zhong B（通讯作者）. Apolipoproteins and liver parameters optimize cardiovascular disease risk-stratification in nonalcoholic fatty liver disease. Dig Liver Dis 2021; 53: 1610-1619. (IF: 5.165)Wu T, Ye J, Shao C, Li F, Lin Y, Ma Q, Wang W, Feng S, Zhong B（通讯作者）. Varied Relationship of Lipid and Lipoprotein Profiles to Liver Fat Content in Phenotypes of Metabolic Associated Fatty Liver Disease. Front Endocrinol (Lausanne) 2021;12:691556.(IF: 6.055)Shi Y, He F, Chen J, Deng H, Shi J, Zhao C, Mi Y, Zou Z, Zhou Y, Di F, Zheng R, Du Q, Shang J, Yang R, Popovic B, Zhong B（通讯作者）, Fan J. Metabolic Disorders Combined with Noninvasive Tests to Screen Advanced Fibrosis in Nonalcoholic Fatty Liver Disease. J Clin Transl Hepatol 2021; 9: 607-614. (IF: 5.065)Li F, Ye J, Sun Y, Lin Y, Wu T, Shao C, Ma Q, Liao X, Feng S, Zhong B（通讯作者）. Distinct Dose-Dependent Association of Free Fatty Acids with Diabetes Development in Nonalcoholic Fatty Liver Disease Patients. Diabetes Metab J 2021; 45: 417-429.(IF: 5.893)Lin Y, Gong X, Li X, Shao C, Wu T, Li M, Li F, Ma Q, Ye J, Zhong B（通讯作者）. Distinct Cause of Death Profiles of Hospitalized Non-alcoholic Fatty Liver Disease: A 10 Years\' Cross-Sectional Multicenter Study in China. Front Med (Lausanne) 2021; 7: 584396.(IF: 5.058)Ye J, Wang W, Feng S, Huang Y, Liao X, Kuang M, Xie X, Liao B, Zhong B（通讯作者）. Precise fibrosis staging with shear wave elastography in chronic hepatitis B depends on liver inflammation and steatosis. Hepatol Int 2020; 14: 190-201. (IF: 9.029)Ye J, Wu Y, Li M, Gong X, Zhong B（通讯作者）. Keratin 8 Mutations Were Associated With Susceptibility to Chronic Hepatitis B and Related Progression. J Infect Dis 2020; 221: 464-473. (IF: 7.759)Shao C, Ye J, Li F, Feng S, Wang W, Zhong B（通讯作者）. Different predictors of steatosis and fibrosis severity among lean, overweight and obese patients with nonalcoholic fatty liver disease. Dig Liver Dis 2019; 51: 1392-1399. (IF: 5.165)Ye J, Hu X, Wu T, Wu Y, Shao C, Li F, Lin Y, Feng S, Wang W, Zhong B（通讯作者）. Insulin resistance exhibits varied metabolic abnormalities in nonalcoholic fatty liver disease, chronic hepatitis B and the combination of the two: a cross-sectional study. Diabetol Metab Syndr 2019; 11: 45. (IF: 5.395)科研基金：主持国家级、省部级和广州市重大专项研究项目多项主编或参编专著：1、脂肪肝看名医(中山大学出版社)2、脂肪肝中西医诊治（中华医学会继续教育教材）3、中华老年医学（人民卫生出版社）4、老年医学专科培训教材5、老年医学住院医师规范化培训教材其他主要工作成绩（比如获奖情况）：多次接受包括羊城晚报、广州日报、新快报、39健康网、腾讯网、广东电台南方生活直播等多家主流媒体采访。